Aim of the present study was to assess changes in Ocrelizumab (OCR) schedule during the first wave of pandemic in Italy and to evaluate the effect of delayed infusion on clinic/radiological endpoints.
No takes yet. Share an insight, caveat, or question.
Bisecco et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: